A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
for Small Cell Lung Cancer Extensive Stage
Drug: Gocatamig
12 locations incl. Santa Rosa
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT07227597·Phase 1, Phase 2·Recruiting